Abstract
Over the past 25 years, pneumococcal conjugate vaccines (PCVs) have markedly reduced both pneumococcal disease and nasopharyngeal carriage caused by vaccine serotypes among the more than 10… [+59261 chars]
Read Full Story
What is driving the resurgence and persistence of vaccine-targeted pneumococcal serotypes?—Serotype 19F as the paradigm
Posted on March 19, 2026 at 